Product Name:4-Bromo-N-isopropylbenzamide
IUPAC Name:4-bromo-N-(propan-2-yl)benzamide
Product Overview |
4-Bromo-N-isopropylbenzamide (4-BIB) is an organic compound with a wide range of applications in biochemistry, pharmacology and other scientific fields. In biochemistry, 4-BIB is used as a reagent for the synthesis of various compounds, and its mechanism of action can be used to study the biochemical and physiological effects of drugs. In pharmacology, 4-BIB is used to study the effects of drug interactions on the body, and its advantages and limitations are useful in designing lab experiments. |
Synthesis and Application |
4-Bromo-N-isopropylbenzamide is synthesized through the reaction of 4-bromo-N-isopropylbenzamide with an acid such as hydrochloric acid. The reaction is catalyzed by a strong base such as potassium hydroxide and proceeds through a nucleophilic substitution mechanism. The reaction can be carried out in either an aqueous or organic medium, and the product can be isolated by crystallization. 4-Bromo-N-isopropylbenzamide has numerous scientific research applications, including drug development, drug-drug interactions, and biochemical and physiological studies. In drug development, 4-Bromo-N-isopropylbenzamide is used to study the effects of drug interactions on the body. In drug-drug interactions, 4-Bromo-N-isopropylbenzamide is used to study the effects of two drugs interacting with each other, and to determine the optimal dose of each drug. In biochemical and physiological studies, 4-Bromo-N-isopropylbenzamide is used to study the biochemical and physiological effects of drugs on the body. |
Future Directions |
The potential future directions for 4-Bromo-N-isopropylbenzamide include its use in drug discovery, drug-drug interactions, and biochemical and physiological studies. Additionally, 4-Bromo-N-isopropylbenzamide could be used to study the effects of drugs on the body, and to develop more effective drugs with fewer side effects. Finally, 4-Bromo-N-isopropylbenzamide could be used to develop new drugs that target specific receptors, and to study the effects of drug-drug interactions on the body. |